Preparation, Characterization and Antioxidant Activities of Kelp Phlorotannin Nanoparticles

• Published in: Molecules (Basel, Switzerland) Vol. 25; no. 19; p. 4550
• Main Authors: Bai, Ying, Sun, Yihan, Gu, Yue, Zheng, Jie, Yu, Chenxu, Qi, Hang
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 05-10-2020; MDPI
• Subjects: Algae; antioxidant activity; Antioxidants; Antioxidants - chemistry; Antioxidants - pharmacokinetics; Antioxidants - pharmacology; Bioavailability; Biocompatibility; Cell Line; characterization; Coated Materials, Biocompatible - chemical synthesis; Coated Materials, Biocompatible - chemistry; Coated Materials, Biocompatible - pharmacokinetics; Coated Materials, Biocompatible - pharmacology; Controlled release; Cosmetics; Delayed-Action Preparations - chemical synthesis; Delayed-Action Preparations - chemistry; Delayed-Action Preparations - pharmacokinetics; Delayed-Action Preparations - pharmacology; encapsulation; Humans; Kelp - classification; Keratinocytes; Keratinocytes - metabolism; Materials Testing; Metabolites; Nanoparticles; Nanoparticles - chemistry; Nanoparticles - therapeutic use; Particle size; phlorotannin; Polymers; Polyvinylpyrrolidone; Povidone - chemistry; Secondary metabolites; stability; Toxicity; encapsulation; phlorotannin; antioxidant activity; characterization; stability
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules25194550

Phlorotannins are a group of major polyphenol secondary metabolites found only in brown algae and are known for their bioactivities and multiple health benefits. However, they can be oxidized due to external factors and their bioavailability is low due to their low water solubility. In this study, the potential of utilizing nanoencapsulation with polyvinylpyrrolidone (PVP) to improve various activities of phlorotannins was explored. Phlorotannins encapsulated by PVP nanoparticles (PPNPS) with different loading ratios were prepared for characterization. Then, the PPNPS were evaluated for in vitro controlled release of phlorotannin, toxicity and antioxidant activities at the ratio of phlorotannin to PVP 1:8. The results indicated that the PPNPS showed a slow and sustained kinetic release of phlorotannin in simulated gastrointestinal fluids, they were non-toxic to HaCaT keratinocytes and they could reduce the generation of endogenous reactive oxygen species (ROS). Therefore, PPNPS have the potential to be a useful platform for the utilization of phlorotannin in both pharmaceutical and cosmetics industries.